| abstract |
The present invention concerns novel uses for human HSP60 in methods of treatment or diagnosis of the human body, more particularly diagnostic test methods, the manufacture of diagnostic tests, and diagnostic test kits for patients with vascular disorders due to atherosclerosis, having a tendency to heat shock protein-induced complement activation, for example to myocardial disorders such as coronary heart disease. |